Healthcare - Biotechnology - NASDAQ - US
$ 5.84
-5.96 %
$ 222 M
Market Cap
-3.74
P/E
INCOME STATEMENT
2.76 M
REVENUE
-51.5 M
OPERATING INCOME
-49.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Orchestra BioMed Holdings, Inc.
| Revenue | 2.76 M |
| Cost Of Revenue | 186 K |
| Gross Profit | 2.57 M |
| Operating Expenses | 54.1 M |
| Operating Income | -51.5 M |
| Other Expenses | -2.39 M |
| Net Income | -49.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 2.8 | 3.5 | (0.8) | 5.7 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 0.2 | 0.3 | 0.2 | 0.1 |
| Gross Profit | 2.6 | 3.2 | (1.0) | 5.6 |
| OPERATING INCOME | ||||
| Operating Expenses | 54.1 | 35.9 | 20.8 | 24.3 |
| Selling, General and Administrative Expenses | 20.3 | 13.9 | 7.9 | 10.8 |
| Research and Development Expenses | 33.8 | 21.9 | 12.9 | 13.5 |
| Operating Income | (51.5) | (32.7) | (21.8) | (18.8) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 0 | 0.9 | 0 |
| Total Other Income | 2.4 | (1.0) | (1.2) | (2.6) |
| Pre-Tax Income | (49.1) | (33.6) | (23.0) | (21.4) |
| NET INCOME | ||||
| Tax Provision | 0 | (0.2) | 0.9 | 2.6 |
| Net Income | (49.1) | (33.6) | (23.0) | (21.4) |
| EPS | 1.48 | 2.24 | 1.13 | 1.04 |